Recognizing and treating anxiety in the elderly

Journal of Clinical Psychiatry

Volumn 58, Issue SUPPL. 3, 1997, Pages 41-50

  Small, Gary W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPRAZOLAM; AMANTADINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; ATENOLOL; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CHLORAL HYDRATE; CHLORDIAZEPOXIDE; CLONAZEPAM; DIAZEPAM; FLUOXETINE; FLURAZEPAM; HYPNOTIC SEDATIVE AGENT; IMIPRAMINE; LORAZEPAM; MIDAZOLAM; NEFAZODONE; OXAZEPAM; PAROXETINE; PROPRANOLOL; QUAZEPAM; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM; TRAZODONE; TRIAZOLAM; VENLAFAXINE;

ANXIETY NEUROSIS; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; HUMAN; INSOMNIA; INTRAVENOUS DRUG ADMINISTRATION; ONSET AGE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

EID: 0030898167     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Flint AJ. Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry 1994;151:640-649
2. Regier DA, Boyd JH, Burke JD Jr, et al. One-month prevalence of mental disorders in the United States: based on five Epidemiologic Catchment Area sites. Arch Gen Psychiatry 1988;45:977-986
3. Bland RC, Newman SC, Orn H. Prevalence of psychiatric disorders in the elderly in Edmonton. Acta Psychiatr Scand Suppl 1988;77(suppl 338):57-63
4. Uhlenhuth EH, Baker MB, Mellinger GD, et al. Symptom checklist syndromes in the general population: correlations with psychotherapeutic drug use. Arch Gen Psychiatry 1983;40:1167-1173
5. Copeland JRM, Dewey ME, Wood N, et al. Range of mental illness among the elderly in the community: prevalence in Liverpool using the GMS-AGECAT package. Br J Psychiatry 1987;150:815-823
6. Bergmann K. The neuroses of old age. In: Kay DWK, Walk A, eds. Recent Developments in Psychogeriatrics: A Symposium. Br J Psychiatry Special Publication 6. Ashford, Kent, England: Headley Brothers; 1971
7. Lindesay J, Briggs K, Murphy E. The Guy's/Age Concern Survey: prevalence rates of cognitive impairment, depression and anxiety in an urban elderly community. Br J Psychiatry 1989;155:317-329
8. Magni G, De Leo D. Anxiety and depression in geriatric and adult medical inpatients: a comparison. Psychol Rep 1984;55:607-612
9. Cassem EH. Depression and anxiety secondary to medical illness. Psychiatr Clin North Am 1990;13:597-612
10. Wands K, Merskey H, Hachinski VC, et al. A questionnaire investigation of anxiety and depression in early dementia. J Am Geriatr Soc 1990;38: 535-538
11. Bachman DL, Wolf PA, Linn R, et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992;42:115-119
12. Brayne C, Gill C, Huppert FA, et al. Incidence of clinically diagnosed subtypes of dementia in an elderly population: Cambridge Project for Later Life. Br J Psychiatry 1995;167:255-262
13. Crook T, Bartus RT, Ferris SH, et al. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change - report of a National Institute of Mental Health Work Group. Developmental Neuropsychology 1986;2:261-276
14. Larrabee GJ, Crook TH. Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr 1994;6:95-104
15. La Rue A, E'Elia LF. Anxiety and problem solving in middle-aged and elderly adults. Exp Aging Res 1985;11:215-220
16. La Rue A, O'Hara R, Matsuyama SS, et al. Cognitive changes in young-old adults: effect of family history of dementia. J Clin Exp Neuropsychol 1995; 17:65-70
17. Ford CV, Sbordone RJ. Attitudes of psychiatrists toward elderly patients. Am J Psychiatry 1980;137:571-575
18. Liebowitz MR, Hollander E, Schneier F, et al. Anxiety and depression: discrete diagnostic entities? J Clin Psychopharmacol 1990;10(suppl 3):61S-66S
19. Alexopoulos GS. Anxiety-depression syndromes in old age. International Journal of Geriatric Psychiatry 1990;5:351-353
20. Eaton WW, Kramer M, Anthony JC, et al. The incidence of specific DIS/ DSM-III mental disorders: data from the NIMH Epidemiologic Catchment Area program. Acta Psychiatr Scand 1989;79:163-168
21. Jenike MA. Geriatric obsessive-compulsive disorder. J Geriatr Psychiatry Neurol 1991;4:34-39
22. Shader RI, Kennedy JS. Psychopharmacology. In: Kaplan HE, Sadock BJ, eds. Comprehensive Textbook of Psychiatry. 6th ed. Baltimore, Md: Williams & Wilkins; 1995:2603-2616
23. Gonski PN, Stathers GM, Frieman JS, et al. A critical review of admission and discharge medications in an elderly Australian population. Drugs Aging 1993;3:358-362
24. Avorn J, Soumerai SB, Everitt DE, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 1992;327:168-173
25. Shorr RI, Robin DW. Rational use of benzodiazepines in the elderly. Drugs Aging 1994;4:9-20
26. Beers M, Avorn J, Soumerai SB, et al. Psychoactive medication use in intermediate-care facility residents. JAMA 1988;260:3016-3020
27. Kales A, Manfredi RL, Vgontzas AN, et al. Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines. Clin Pharmacol Ther 1991;49:468-471
28. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989;262:3303-3307
29. Freeman AM, Fleece L, Folks DG, et al. Alprazolam treatment of postcoronary bypass anxiety and depression. J Clin Psychopharmacol 1986;6:39-41
30. Hart RP, Colenda CC, Hamer RM. Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects. Am J Psychiatry 1991; 148:73-77
31. Salzman C, Fisher J, Nobel K, et al. Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. International Journal of Geriatric Psychiatry 1992;7:89-93
32. Böhm C, Robinson DS, Gammans RE, et al. Buspirone therapy in anxious elderly patients: a controlled clinical trial. J Clin Psychopharmacol 1990; 10(suppl3):47S-51S
33. Lawlor BA, Hill JL, Radcliffe JL, et al. A single oral dose challenge of buspirone does not affect memory processes in older volunteers. Biol Psychiatry 1992;32:101-103
34. Colenda CC. Buspirone in treatment of agitated demented patient. Lancet 1988;1:1169
35. Holzer JC, Gitelman DR, Price BH. Efficacy of buspirone in the treatment of dementia with aggression [letter]. Am J Psychiatry 1995;152:812
36. Sakauye KM, Camp CJ, Ford PA. Effects of buspirone on agitation associated with dementia. American Journal of Geriatric Psychiatry 1993;1: 82-84
37. McInnes E, Powell J. Drug and alcohol referrals: are elderly substance abuse diagnoses and referrals being missed? BMJ 1994;308:444-446
38. Small GW, Hamilton SL, Bystritsky A, et al. Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Intl Psychogeriatr 1995;7(suppl):41-53
39. Tollefson GD, Greist JH, Jefferson JW, et al. Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: a comparative trial of fluoxetine versus imipramine. J Clin Psychopharmacol 1994;14: 385-391
40. van Laar MW, van Willigenburg AP, Volkerts ER. Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects. J Clin Psychopharmacol 1995;15:30-40
41. Sunderland T, Lawlor BA, Martinez RA, et al. Anxiety in the elderly: neurobiological and clinical interface. In: Salzman C, Lebowitz BD, eds. Anxiety in the Elderly: Treatment and Research. New York, NY: Springer; 1991
42. Steuer JL, Mintz J, Hammen CL, et al. Cognitive-behavioral and psychodynamic group psychotherapy in treatment of geriatric depression. J Consult Clin Psychol 1984;52:180-189
43. Scoggin F, McElreath L. Efficacy of psychosocial treatments for geriatric depression: a quantitative review. J Consult Clin Psychol 1994;62:69-74